CVS HEALTH CORPORATION Income (Loss) from Continuing Operations before Income Taxes, Domestic
CVS HEALTH CORPORATION (CVS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $1.33 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-10
- CVS HEALTH CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $1.33B, a 77.62% decline from fiscal 2024.
- CVS HEALTH CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $5.96B, a 46.30% decline from fiscal 2023.
- CVS HEALTH CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $11.11B.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $1.33B 10-K · filed 2026-02-10 |
| 2024-12-31 | $5.96B 10-K · filed 2026-02-10 |
| 2023-12-31 | $11.11B 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |